Citation Impact
Citing Papers
Oxidative Stress
2017 Standout
Hypoxia — a key regulatory factor in tumour growth
2002 Standout
Nasopharyngeal carcinoma
2005 Standout
Prevalence of Depression in Patients With Cancer
2004 Standout
Nutrition impact symptoms: Key determinants of reduced dietary intake, weight loss, and reduced functional capacity of patients with head and neck cancer before treatment
2009
Venous Thromboembolism and Mortality Associated With Recombinant Erythropoietin and Darbepoetin Administration for the Treatment of Cancer-Associated Anemia
2008
Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fractionation (6 fractions per week) in comparison with conventional fractionation (5 fractions per week): report on 3-year tumor control and normal tissue toxicity
2001
Photodynamic Therapy
1998 Standout
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies
2011 Standout
Intracellular Localization of Photosensitizers
2007
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
Lung Cancer
2008 Standout
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results
1991
Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy
2004
Definition and classification of cancer cachexia: an international consensus
2011 Standout
Photodynamic therapy for cancer
2003 Standout
Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cellsin vitro
2005
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Effect of drug‐light interval on photodynamic therapy with meta‐tetrahydroxyphenylchlorin in malignant mesothelioma
1993
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
A phase II study of primary reirradiation in squamous cell carcinoma of head and neck
2006
An investigation of psychological distress in patients who have beentreated for head and neck cancer
2001
Milestones in the development of photodynamic therapy and fluorescence diagnosis
2007
Using molecular beacons for cancer imaging and treatment
2007
A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
2000 Standout
THE PHOTODEGRADATION OF PORPHYRINS IN CELLS CAN BE USED TO ESTIMATE THE LIFETIME OF SINGLET OXYGEN
1991
Psychiatric disorders and mental health service use in patients with advanced cancer
2005
Nasopharyngeal carcinoma
2015 Standout
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
Variable cytocompatibility of six cell lines with photoinitiators used for polymerizing hydrogels and cell encapsulation
2004 Standout
Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization
2002
The validity of the Hospital Anxiety and Depression Scale
2002 Standout
Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas
2002
POTENCY AND SELECTIVE TOXICITY OF TETRA(HYDROXYPHENYL)‐ AND TETRAKIS(DIHYDROXYPHENYL)PORPHYRINS IN HUMAN MELANOMA CELLS, WITH AND WITHOUT EXPOSURE TO RED LIGHT
1994
ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer (EORTC)
2000
An efficient recognition motif for an alkyl moiety in water
2003 StandoutNobel
Photodynamic therapy of cancer: An update
2011 Standout
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
2001 Standout
The interpersonal theory of suicide.
2010 Standout
Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications
2000
Prediction of depression 6 months to 3 years after treatment of head and neck cancer
2001
Photodynamic therapy in dermatology
2000
Altered Fractionation and/or Adjuvant Chemotherapy in Definitive Irradiation of Squamous Cell Carcinoma of the Head and Neck
2003
Evaluation of a new photosensitizer, meso‐tetra‐hydroxyphenyl‐chlorin, for use in photodynamic therapy: A comparison of its photobiological properties with those of two other photosensitizers
1994
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
2012 StandoutNobel
Correlation of Subcellular and Intratumoral Photosensitizer Localization with Ultrastructural Features After Photodynamic Therapy
1996
Head and Neck Cancer
2001 Standout
Drug Resistance and the Solid Tumor Microenvironment
2007 Standout
Quality of Life and Head and Neck Cancer: A 5 Year Prospective Study
2005
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Characterization of reactive oxygen species generated by protoporphyrin IX under X-ray irradiation
2009
Photosensitized destruction of human bladder carcinoma cells treated with chlorin e6-conjugated microspheres.
1991
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Immunophotodynamic therapy: Current developments and future prospects
1997
Near-Infrared-Absorbing Gold Nanopopcorns with Iron Oxide Cluster Core for Magnetically Amplified Photothermal and Photodynamic Cancer Therapy
2015
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
The Photobiology of Photodynamic Therapy: Cellular Targets and Mechanisms
1998
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
2002 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells
2010
A Brief Measure for Assessing Generalized Anxiety Disorder
2006 Standout
Basic principles of photodynamic therapy
2001 Standout
Alcoholism, depression, and abnormal cognition in head and neck cancer: A pilot study
2007
ACCUMULATION OF PORPHYRINS IN CELLS: INFLUENCE OF HYDROPHOBICITY AGGREGATION AND PROTEIN BINDING
1988
PHTHALOCYANINES AS PHOTODYNAMIC SENSITIZERS*
1991
Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck
2001
Synthesis and Biolocalization of Water-Soluble Sapphyrins
2002
BODIPY dyes in photodynamic therapy
2012 Standout
New photosensitizers for photodynamic therapy
2016 Standout
Suicide Risk in Cancer Patients From 1960 to 1999
2004
Chemistry of Biologically Important Synthetic Organoselenium Compounds
2001 Standout
Hyaluronan-decorated polymer nanoparticles targeting the CD44 receptor for the combined photo/chemo-therapy of cancer
2015
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
The Chemistry of Neutron Capture Therapy
1998 Standout
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Water-Soluble Conjugated Polymers for Imaging, Diagnosis, and Therapy
2012 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Synthesis of β-Galactose-Conjugated Chlorins Derived by Enyne Metathesis as Galectin-Specific Photosensitizers for Photodynamic Therapy
2001
The exciton model in molecular spectroscopy
1965 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Oxygen Dependency of Tumor Cell Killing in Vitro by Light-Activated Photofrin II
1991
Safety and Efficacy of Darbepoetin Alfa in Previously Untreated Extensive-Stage Small-Cell Lung Cancer Treated With Platinum Plus Etoposide
2008
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy
1995 Standout
Glycosylated Porphyrins: Characterization of Association in Aqueous Solutions by Absorption and Fluorescence Spectroscopies and Determination of Singlet Oxygen Yield in Organic Media
1998
Works of J. Evensen being referenced
A Prospective Study of Quality of Life in Head and Neck Cancer Patients. Part II: Longitudinal Data
2001
A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients
1999
A Prospective Study of Quality of Life in Head and Neck Cancer Patients. Part I: At Diagnosis
2001
Acute and late normal tissue reactions in the DAHANCA 6&7 randomized trial with accelerated radiotherapy for head and neck cancer
2003
Photodynamic action and chromosomal damage: A comparison of haematoporphyrin derivative (HpD) and light with X-irradiation
1982
PHOTOSENSITIZING EFFICIENCIES, TUMOR‐ and CELLULAR UPTAKE OF DIFFERENT PHOTOSENSITIZING DRUGS RELEVANT FOR PHOTODYNAMIC THERAPY OF CANCER
1987
106 Conventional radiotherapy as primary treatment of squamous cell carcinoma of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week-report from the Dahanca 7 trial
1997
6LB Randomized study of the importance of Novel Erythropoiesis Stimulating Protein (Aranesp®) for the effect of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC) – the Danish Head and Neck Cancer Group DAHANCA 10 randomized trial
2007